ML327 induces apoptosis and sensitizes Ewing sarcoma cells to TNF-related apoptosis-inducing ligand
- 1 September 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 491 (2) , 463-468
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 DK61470)
- American College of Surgeons Resident Research Scholarship
- Rally Foundation for Cancer Research
- Vanderbilt Ingram Cancer Center (P30 CA68485)
- Vanderbilt Digestive Disease Research Center (DK058404)
This publication has 21 references indexed in Scilit:
- Molecular mechanisms of epithelial–mesenchymal transitionNature Reviews Molecular Cell Biology, 2014
- Children's Oncology Group's 2013 blueprint for research: Bone tumorsPediatric Blood & Cancer, 2012
- Ewing Sarcoma: Clinical State-of-the-ArtPediatric Hematology and Oncology, 2012
- Identification and Optimization of Small Molecules That Restore E-Cadherin Expression and Reduce Invasion in Colorectal Carcinoma CellsACS Chemical Biology, 2011
- MS-275 Sensitizes TRAIL-Resistant Breast Cancer Cells, Inhibits Angiogenesis and Metastasis, and Reverses Epithelial-Mesenchymal Transition In vivoMolecular Cancer Therapeutics, 2010
- Mesenchymal Stem Cells and the Origin of Ewing's SarcomaSarcoma, 2010
- Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal SurvivalClinical Cancer Research, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Interferon γ Enhances the Effectiveness of Tumor Necrosis Factor-Related Apoptosis–Inducing Ligand Receptor Agonists in a Xenograft Model of Ewing’s SarcomaCancer Research, 2004
- Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosisCell Death & Differentiation, 2001